Nektar Therapeutics · NASDAQ:NKTR

Zalevsky Jonathan sold 192 Nektar Therapeutics shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Zalevsky Jonathan (Chief R&D Officer) sold 192 Nektar Therapeutics shares at US$35.85 for US$6,883, leaving 9,378 shares. Filed Nov 19, 2026 (Form 4).

Sold
192 shares
Price
US$35.85
Value
US$6,883
Holding after
9,378 shares
Trading plan
No
Role
Chief R&D Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale192US$35.859,378Direct

Source

Download original · View original at SEC

Related